{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:22:34Z","timestamp":1770495754156,"version":"3.49.0"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2023,4,30]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>More than 3\u2009million Australians are estimated to have migraine disorders, and over a quarter of a million Australians are estimated to have medication overuse headache (MOH). The personal, societal and economic burden of MOH is high. MOH impacts an individual\u2019s ability to work or study, care for family or themselves, culminating in poor quality of life. Accurate and timely diagnosis and treatment of MOH are imperative. Withdrawal failures and relapse rates are high in MOH.<\/jats:p>\n               <jats:p>Treatment of MOH is aimed at ceasing medication overuse and reducing monthly migraine days with the aim of achieving a pattern of well-controlled episodic migraine. Current treatment approaches in routine practice include withdrawal with preventive treatment, withdrawal with optional preventive treatment in the subsequent weeks and preventive treatment without withdrawal. This viewpoint article provides an overview of managing MOH in Australian clinical practice, with a focus on the importance of patient education and the role of preventive treatment in supporting patients as they withdraw from acute migraine medication(s).<\/jats:p>","DOI":"10.1136\/bmjno-2023-000418","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T11:20:10Z","timestamp":1685532010000},"page":"e000418","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Assessing and managing medication overuse headache in Australian clinical practice"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-7111","authenticated-orcid":false,"given":"Tissa","family":"Wijeratne","sequence":"first","affiliation":[{"name":"Department of Neurology, Sunshine Hospital, St Albans, Victoria, Australia"},{"name":"Department of Medicine, Sunshine Hospital, St Albans, Victoria, Australia"},{"name":"The Institute for Health and Sport (IHES), Victoria University, Melbourne, Victoria, Australia"},{"name":"Department of Psychology, RMIT University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal North Shore Hospital, St Leonards, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"Stark","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosciences, Alfred Hospital Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Neurology, Monash University, Clayton, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Sun-Edelstein","sequence":"additional","affiliation":[{"name":"Department of Neurology, St Vincent\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"2025072812162777000_5.1.e000418.1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"2025072812162777000_5.1.e000418.2","unstructured":"Fischer MA , Headache A . Medication-overuse headache. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538150\/"},{"key":"2025072812162777000_5.1.e000418.3","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-018-0875-x","article-title":"Medication-overuse headache: a widely recognized entity amidst ongoing debate","volume":"19","author":"Vandenbussche","year":"2018","journal-title":"J Headache Pain"},{"key":"2025072812162777000_5.1.e000418.4","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/j.pain.0000000000002275","article-title":"Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019","volume":"163","author":"Safiri","year":"2022","journal-title":"Pain"},{"key":"2025072812162777000_5.1.e000418.5","unstructured":"Australian Bureau Statistics . National, state and territory population. 2019. Available: https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/dec-2019"},{"key":"2025072812162777000_5.1.e000418.6","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614522683"},{"key":"2025072812162777000_5.1.e000418.7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ane.13475","article-title":"Withdrawal failure in patients with chronic migraine and medication overuse headache","volume":"144","author":"D\u2019Amico","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"2025072812162777000_5.1.e000418.8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/03331024211067791","article-title":"Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache","volume":"42","author":"Pensato","year":"2022","journal-title":"Cephalalgia"},{"key":"2025072812162777000_5.1.e000418.9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40263-021-00818-9","article-title":"The evolution of medication overuse headache: history, pathophysiology and clinical update","volume":"35","author":"Sun-Edelstein","year":"2021","journal-title":"CNS Drugs"},{"key":"2025072812162777000_5.1.e000418.10","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci6030030","article-title":"Medication-overuse headache: differences between daily and near-daily headache patients","volume":"6","author":"Krymchantowski","year":"2016","journal-title":"Brain Sci"},{"key":"2025072812162777000_5.1.e000418.11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/1742-6723.13504","article-title":"Overuse of opioids for acute migraine in an Australian emergency department","volume":"32","author":"Gunasekera","year":"2020","journal-title":"Emerg Med Australas"},{"key":"2025072812162777000_5.1.e000418.12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/head.14217","article-title":"The headache in emergency departments study: opioid prescribing in patients presenting with headache. A multicenter, cross-sectional, observational study","volume":"61","author":"Pellatt","year":"2021","journal-title":"Headache"},{"key":"2025072812162777000_5.1.e000418.13","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50552"},{"key":"2025072812162777000_5.1.e000418.14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.18773\/austprescr.2005.109","article-title":"Medication overuse headache","volume":"28","author":"Williams","year":"2005","journal-title":"Aust Prescr"},{"key":"2025072812162777000_5.1.e000418.15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/head.14195","article-title":"Medication overuse headache in patients with chronic migraine using Cannabis: a case-referent study","volume":"61","author":"Zhang","year":"2021","journal-title":"Headache"},{"key":"2025072812162777000_5.1.e000418.16","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1945-17.2017"},{"key":"2025072812162777000_5.1.e000418.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-018-0784-z","article-title":"Engaging patients to improve quality of care: a systematic review","volume":"13","author":"Bombard","year":"2018","journal-title":"Implement Sci"},{"key":"2025072812162777000_5.1.e000418.18","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14268"},{"key":"2025072812162777000_5.1.e000418.19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.842082","article-title":"Intravenous lidocaine and ketamine infusions for headache disorders: a retrospective cohort study","volume":"13","author":"Ray","year":"2022","journal-title":"Front Neurol"},{"key":"2025072812162777000_5.1.e000418.20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 treatment strategies for MOH: a randomized clinical trial","volume":"77","author":"Carlsen","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025072812162777000_5.1.e000418.21","doi-asserted-by":"crossref","first-page":"e1409","DOI":"10.1212\/WNL.0000000000200117","article-title":"Patient-centered treatment of chronic migraine with medication overuse: a prospective, randomized","volume":"98","author":"Schwedt","year":"2022","journal-title":"Neurology"},{"key":"2025072812162777000_5.1.e000418.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00684.x"},{"key":"2025072812162777000_5.1.e000418.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01508.x"},{"key":"2025072812162777000_5.1.e000418.24","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.000022888.49044.99"},{"key":"2025072812162777000_5.1.e000418.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.05.003"},{"key":"2025072812162777000_5.1.e000418.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.01990.x"},{"key":"2025072812162777000_5.1.e000418.27","unstructured":"Clinicaltrials.gov . A study of Eptinezumab in participants with migraine and medication Overuse headache (Nct05452239). n.d. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05452239?term=RESOLUTION&cond=eptinezumab&draw=2"},{"key":"2025072812162777000_5.1.e000418.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-011-0364-y"},{"key":"2025072812162777000_5.1.e000418.29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.12809\/hkmj177024","article-title":"Medication overuse headache: strategies for prevention and treatment using a multidisciplinary treatment approach","volume":"24","author":"van Driel","year":"2018","journal-title":"Hong Kong Med J"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2023-000418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:16:35Z","timestamp":1753730195000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2023-000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,31]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/bmjno-2023-000418"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2023-000418","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}